NCT02515214

Brief Summary

The use of bariatric surgery has risen subsequently over the last decade, especially in women of reproductive age. (Unplanned) pregnancies in this subgroup are not rare because of e.g. an increased fertility (because of the weight loss) and a possible ineffectiveness of contraceptives (because of a malabsorption in the intestine). Although a pregnancy after bariatric surgery is generally known as safe, there are a few studies that indicate that a pregnancy after a bariatric surgery is not always without complications, and that it should be considered as a high risk pregnancy. The research on pregnancy outcomes after this type of surgery is rather limited to a few small, mainly retrospective, observational case-control and cohort studies and a limited amount of case studies. For risk- and prognose related issues, e.g. the effect of bariatric surgery on fertility, timing of the pregnancy, development of complications during the pregnancy and pregnancy outcomes, large prospective cohort studies are needed. Besides, breast feeding practices and breast milk composition have scarcely been investigated in this population. The energy content of breast milk could possibly be influenced by a state of malabsorption after the procedure. Low amounts of vitamin B12 have also been noticed in the breast milk of women the surgery. The overall objective of this study is to establish a group of women at reproductive age (age 18-45) with a history of bariatric surgery and to generate an extensive database for future analysis. The final goal of the researchers is to develop guidelines or recommendations on how to manage pregnancies after bariatric surgery, based on large-scale prospective research. The study design is a multicentric observational and prospective cohort study. Participants will be followed from the moment of surgery until 6 months postpartum and they can be included on several time points (before surgery, after surgery (\<12 months); after surgery (\>12 months) or during the pregnancy). Both retrospective and prospective data concerning the medical background, fertility (menstrual cycle), lifestyle (e.a. food, physical activities, smoking, sleeping), blood samples, psychological factors (fear and depression), sexuality, quality of life and pregnancy outcomes will be collected. Data collection by the investigators will happen in a web-based database and by direct online registration by the subjects.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2012

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

July 23, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 4, 2015

Completed
9.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

May 7, 2021

Status Verified

May 1, 2021

Enrollment Period

12.5 years

First QC Date

July 23, 2015

Last Update Submit

May 4, 2021

Conditions

Keywords

bariatric surgeryreproduction

Outcome Measures

Primary Outcomes (6)

  • Gestational weight gain

    Weight at birth minus weight at start of pregnancy

    Birth

  • Gestational length

    Preterm (\<37w of gestation) vs a term (37-42w of gestation) delivery

    Birth

  • Surgical complications during pregnancy

    bowel obstruction, strangulation, internal herniation

    up to birth

  • Gestational diabetes mellitus

    disturbed glucose metabolism

    up to birth

  • Hypertensive disorders

    pregnancy-induced hypertension, (pre-)eclampsia

    up to birth

  • Birth weight

    Weight of newborn baby (\<2.5kg small-for-gestational age; \>4kg macrosomia)

    Birth

Secondary Outcomes (28)

  • Quality of life assessed by the Moorehead-Ardelt Quality of Life Questinnaire II

    preoperatively, postoperatively (6 and 12mo), pregnancy trimester 1 (12w), 2 (20-24w) and 3 (28-32w) and postpartum period (6w and 6 mo)

  • Breast milk fat content

    weekly from day 3-4 after delivery until week 6 after delivery

  • Contraception

    baseline, postoperatively (6 and 12mo)

  • Physical activity

    baseline, postoperatively (6 and 12mo), pregnancy trimester 1 (12w), 2 (20-24w) and 3 (28-32w) and postpartum period (6 mo)

  • Dietary intake

    baseline, postoperatively (6 and 12mo), pregnancy trimester 1 (12w), 2 (20-24w) and 3 (28-32w) and postpartum period (6 mo)

  • +23 more secondary outcomes

Other Outcomes (7)

  • Maternal age

    baseline

  • Nationality

    baseline

  • Family status

    baseline

  • +4 more other outcomes

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

1. Women of reproductive age attending for bariatric surgery 2. Women of reproductive age with a history of bariatric surgery 3. Pregnant women with a history of bariatric surgery 4. Lactating women with a history of bariatric surgery

You may not qualify if:

  • IM1
  • Women
  • Age between 18 and 45 years
  • planning bariatric surgery
  • \- Infertile (eg, hysterectomy, menopause, etc.)
  • IM2
  • Women
  • Age between 18 and 45 years
  • A bariatric surgery in the past
  • \- Infertile (eg, hysterectomy, menopause, etc.)
  • IM3
  • Women
  • Age between 18 and 45 years
  • A bariatric surgery in the past
  • \<15 weeks pregnant
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven

Leuven, 3000, Belgium

RECRUITING

Related Publications (2)

  • Jans G, Devlieger R, De Preter V, Ameye L, Roelens K, Lannoo M, Van der Schueren B, Verhaeghe J, Matthys C. Bariatric Surgery Does Not Appear to Affect Women's Breast-Milk Composition. J Nutr. 2018 Jul 1;148(7):1096-1102. doi: 10.1093/jn/nxy085.

  • Jans G, Matthys C, Bel S, Ameye L, Lannoo M, Van der Schueren B, Dillemans B, Lemmens L, Saey JP, van Nieuwenhove Y, Grandjean P, De Becker B, Logghe H, Coppens M, Roelens K, Loccufier A, Verhaeghe J, Devlieger R. AURORA: bariatric surgery registration in women of reproductive age - a multicenter prospective cohort study. BMC Pregnancy Childbirth. 2016 Jul 29;16(1):195. doi: 10.1186/s12884-016-0992-y.

Related Links

Biospecimen

Retention: SAMPLES WITHOUT DNA

Breast milk samples

Study Officials

  • Roland Devlieger, MD, PhD

    KU Leuven, Dpt. Of Development and Regeneration; UZ Leuven, Dpt. of Obstetrics and Gynecology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Roland Devlieger, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof. dr.

Study Record Dates

First Submitted

July 23, 2015

First Posted

August 4, 2015

Study Start

July 1, 2012

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

May 7, 2021

Record last verified: 2021-05

Locations